Navigation Links
Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
Date:5/20/2008

rcentage of men who received this treatment maintained normal testosterone levels while receiving an injection every 10 weeks. This form of testosterone treatment would thus require only five injections per year. This would be an appealing alternative for many men, who may object to existing testosterone treatments such as twice-monthly injections or daily skin application of gels or patches."

About the Study

This Phase III study was a multi-center, open-label, randomized US trial designed to assess the pharmacokinetics, safety, and efficacy of NEBIDO in men with primary or secondary hypogonadism. The trial enrolled a total of 130 hypogonadal men (serum testosterone below 300 ng/dL, at least 18 years of age) that met the study inclusion criteria. Patients received injections of 750 mg of NEBIDO at baseline, week 4, and week 14 of the study, and were followed for an additional 10 weeks. Of the 130 men who participated in the trial, 117 patients were eligible for pharmacokinetics evaluations.

In the study, pharmacokinetic objectives were achieved, with 94 percent of patients reaching and maintaining normal serum testosterone levels. Additionally, secondary endpoints of mood and sexual function also improved. The most commonly reported possibly-related adverse events in the trial were acne (4.6 percent), fatigue (3.1 percent), and injection site pain (3.1 percent).

About NEBIDO

NEBIDO(R) is a long-acting depot preparation of testosterone undecanoate, developed for the treatment of male hypogonadism. NEBIDO is expected to be the first long-acting testosterone preparation available in the U.S. in the growing market for testosterone therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005.

About Hypogonadism

Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Today, there are an estimate
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
2. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
3. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
4. Indevus Announces Submission of New Drug Application
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
7. Napo Presents at ISPOR Meeting in Toronto
8. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
9. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The non-invasive & minimally invasive cardiac output monitoring devices market is estimated ... Europe is segmented as Germany , U.K., ... Rest of Europe (RoE). Germany holds ... cardiac output monitoring devices market around 35.2% in 2014 followed by France ... , Sweden , Poland , Switzerland ...
(Date:4/21/2015)... 21, 2015 Whitehall-based ... dazzling export-led growth in just 4 years. ... part in winning the Queen,s Award for Enterprise, ... Oxford PharmaGenesis. As part of the world,s first ... bring new medicines to the world in areas ...
(Date:4/21/2015)... 2015 This report analyzes the worldwide markets ... Types: Equipment for Therapeutic Apheresis, and Equipment for Donor ... Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others. The report provides separate ... , Japan , Europe ... of World. Annual estimates and forecasts are provided for ...
Breaking Medicine Technology:European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
... CAUSE NO. 2010-10259, , BRAD KOVNAT, ... , ... , v. ... , THE PALLADIUM FOR SURGERY- ...
... BRISBANE, Calif. , Feb. 17 InterMune, Inc. ... the fourth quarter and 12 months ended December 31, ... business activities, and previewed upcoming milestones in 2010.   , ... of InterMune said, "Fourth quarter and recent events have been ...
Cached Medicine Technology:Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 2InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 3InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 4InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 5InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 6InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 7InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 8InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 9InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 10InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 11InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 12
(Date:4/21/2015)... The International Journal of Chronic Obstructive Pulmonary ... and its association with smoking in the Mainland China: ... from ten diverse areas ”. , As corresponding author ... of the world’s cigarettes, but the substantial increases in ... for the full eventual health consequences to be seen. ...
(Date:4/21/2015)... Francisco, CA and Orlando, FL (PRWEB) April 21, ... Behavioral Health (National Council) will honor Dina Tyler, ... Services for PREP (Prevention and Recovery in Early ... National Council Award of Excellence: Peer Specialist of ... awards ceremony, known as the Oscars of behavioral ...
(Date:4/21/2015)... Among parents of children with autism ... as fair or poor, according to a study in ... a visit to the dentist can present many challenges ... the strange smells, loud noises, and sharp tools; the ... of the whole process—not knowing what will happen and ...
(Date:4/21/2015)... The report “Sinusitis – ... on the therapeutic development for Sinusitis. The ... targets and MOAs to produce first-in-class and ... available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html . , ... in the therapeutic development for Sinusitis and ...
(Date:4/21/2015)... April 21, 2015 Wireless Analytics, ... has been recognized by the Boston Business Journal as ... ranking was announced at a recent event celebrating the ... of the fastest-growing private companies in Massachusetts. , Wireless ... the state that recorded the fastest revenue growth from ...
Breaking Medicine News(10 mins):Health News:COPD and smoking in the Mainland China published by Dove Medical Press 2Health News:COPD and smoking in the Mainland China published by Dove Medical Press 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
... ask people how much they plan to exercise, they,ll exercise morebut ... in the Journal of Consumer Research . "When people ... in a behavior (say, if the behavior is how much to ... in the next week makes them think about what they think ...
... Today, during the 89th General Session & Exhibition of ... with the 40th Annual Meeting of the American Association ... the Canadian Association for Dental Research, lead researcher Z. ... titled "Fuz is Essential for Craniofacial and Tooth Development." ...
... Today, during the 89th General Session & Exhibition ... conjunction with the 40th Annual Meeting of the American ... of the Canadian Association for Dental Research, lead researcher ... research study titled "Sealing Manifest Occlusal Caries in Permanent ...
... 17 (HealthDay News) -- It,s normal and healthy for ... housing assistance, according to a new study. The ... involves slacker young adults who refuse to grow up ... children,s development, said the researchers. They analyzed data ...
... HealthDay Reporter , THURSDAY, March 17 (HealthDay ... significantly improved the tremors, rigidity and other motor skill ... new study reports. The phase 2 study enrolled ... half randomly assigned to receive the gene therapy and ...
... Researchers at Boston University School of Medicine (BUSM), in ... new biomarker and therapeutic target for melanoma. The novel ... the process behind tumor metastasis and may allow the ... now appear online in Cancer Research . ...
Cached Medicine News:Health News:Getting healthy: When does prediction help people change their habits? 2Health News:Sealing manifest occlusal caries in permanent teeth -- 2.5-year results 2Health News:Young Adults May Need 'Safety Net' 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:Researchers discover possible biomarker and therapeutic target for melanoma 2
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
... has expanded memory capabilities for overnight sleep screening., ... oxygen saturation and pulse rate data, and can ... your needs:, ,1. The Model 130 can ... a single patient, making the device ideally suited ...
... Cost-effective, portable, continuous, or ... system with alarms and an ... Home-Use and Sleep Study modes ... in the hospital or clinical ...
... The Autocorr Plus, the fourth in ... versatile pulse oximeter/ECG/Respiration Monitor, with 3 ... digital oximetry with SAC (Serial Autocorrelation) ... electroluminescent screen display provides two user ...
Medicine Products: